During the past decade, Miller-Dwan Hospital conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 152 clinical trials were completed, i.e. on average, 143.4% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 50 clinical trials were completed. i.e. 131.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Miller-Dwan Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 105 trials, followed by "Alliance for Clinical Trials in Oncology" with 94 trials sponsored, "SWOG Cancer Research Network" with 41 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored and "Eastern Cooperative Oncology Group" with 19 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miller-Dwan Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 195 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "Eastern Cooperative Oncology Group" with 10 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Miller-Dwan Hospital" are "Breast Cancer" (32 trials), "Lung Cancer" (16 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (13 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Miller-Dwan Hospital" in a lesser frequency.

Most popular intervention types in "Miller-Dwan Hospital" are "Drug" (247 trials), "Other" (153 trials), "Biological" (123 trials), "Procedure" (56 trials) and "Radiation" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (67 trials), "Quality-of-Life Assessment" (44 trials), "placebo" (34 trials), "Paclitaxel" (25 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "Miller-Dwan Hospital" are 248 trials for "All" genders, 38 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Miller-Dwan Hospital". undefined are not yet recruiting, 43 are recruiting, 80 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 150 completed trials in Miller-Dwan Hospital, 5 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Miller-Dwan Hospital, 15 "Phase 1" clinical trials were conducted, 141 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Miller-Dwan Hospital has several departments that took part in Clinical trials: "Essentia Health Cancer Center-South University Clinic" - 115 trials, "Essentia Health Cancer Center" - 280 trials, "St Mary's Duluth Clinic Regional Heart Center" - 13 trials, "Dakota Cancer Institute at Innovis Health - Dakota Clinic" - 12 trials, "Essentia Health NCI Community Oncology Research Program" - 2 trials